167 related articles for article (PubMed ID: 30235476)
21. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
[TBL] [Abstract][Full Text] [Related]
22. Platelet Function Testing after Transcatheter Aortic Valve Implantation.
Capodanno D; Greco A
Thromb Haemost; 2018 Oct; 118(10):1681-1685. PubMed ID: 30273951
[No Abstract] [Full Text] [Related]
23. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.
Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H
Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810
[TBL] [Abstract][Full Text] [Related]
24. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
[TBL] [Abstract][Full Text] [Related]
25. Validation of Three Platelet Function Tests for Bleeding Risk Stratification During Dual Antiplatelet Therapy Following Coronary Interventions.
Kim MH; Choi SY; An SY; Serebruany V
Clin Cardiol; 2016 Jul; 39(7):385-90. PubMed ID: 27355612
[TBL] [Abstract][Full Text] [Related]
26. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
[TBL] [Abstract][Full Text] [Related]
27. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
[TBL] [Abstract][Full Text] [Related]
28. The challenge for predicting bleeding events by assessing platelet reactivity following coronary stenting.
Choi SY; Kim MH; Serebruany V
Int J Cardiol; 2016 Mar; 207():128-31. PubMed ID: 26800135
[TBL] [Abstract][Full Text] [Related]
29. Incidence, Predictors and Impact of Severe Periprocedural Bleeding According to VARC-2 Criteria on 1-Year Clinical Outcomes in Patients After Transcatheter Aortic Valve Implantation.
Kochman J; Rymuza B; Huczek Z; Kołtowski Ł; Ścisło P; Wilimski R; Ścibisz A; Stanecka P; Filipiak KJ; Opolski G
Int Heart J; 2016; 57(1):35-40. PubMed ID: 26673439
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcomes and Bioprosthetic Valve Function After Transcatheter Aortic Valve Implantation Under Dual Antiplatelet Therapy vs. Aspirin Alone.
Ichibori Y; Mizote I; Maeda K; Onishi T; Ohtani T; Yamaguchi O; Torikai K; Kuratani T; Sawa Y; Nakatani S; Sakata Y
Circ J; 2017 Feb; 81(3):397-404. PubMed ID: 28123149
[TBL] [Abstract][Full Text] [Related]
31. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.
Mayer K; Schulz S; Bernlochner I; Morath T; Braun S; Hausleiter J; Massberg S; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D
Thromb Haemost; 2014 Aug; 112(2):342-51. PubMed ID: 24718389
[TBL] [Abstract][Full Text] [Related]
32. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a clinical case series.
Higuchi R; Tobaru T; Hagiya K; Saji M; Takamisawa I; Shimizu J; Iguchi N; Takanashi S; Takayama M; Isobe M
Heart Vessels; 2018 Nov; 33(11):1343-1349. PubMed ID: 29721672
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.
Furuta A; Lellouche N; Mouillet G; Dhanjal T; Gilard M; Laskar M; Eltchaninoff H; Fajadet J; Iung B; Donzeau-Gouge P; Leprince P; Leuguerrier A; Prat A; Dubois-Rande JL; Teiger E
Int J Cardiol; 2016 May; 210():72-9. PubMed ID: 26930641
[TBL] [Abstract][Full Text] [Related]
35. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
36. Single versus dual anti-platelet therapy post transcatheter aortic valve implantation: a meta-analysis of randomized controlled trials.
Ando T; Takagi H; Briasoulis A; Afonso L
J Thromb Thrombolysis; 2017 Nov; 44(4):448-456. PubMed ID: 28905178
[TBL] [Abstract][Full Text] [Related]
37. Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths.
Ando T; Takagi H; Grines CL
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):484-492. PubMed ID: 28549125
[TBL] [Abstract][Full Text] [Related]
38. Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Watanabe Y; Kozuma K; Ishikawa S; Hosogoe N; Isshiki T
Int Heart J; 2016; 57(2):190-7. PubMed ID: 26973266
[TBL] [Abstract][Full Text] [Related]
39. Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.
O'Connor SA; Morice MC; Gilard M; Leon MB; Webb JG; Dvir D; Rodés-Cabau J; Tamburino C; Capodanno D; D'Ascenzo F; Garot P; Chevalier B; Mikhail GW; Ludman PF
J Am Coll Cardiol; 2015 Jul; 66(3):221-228. PubMed ID: 26184614
[TBL] [Abstract][Full Text] [Related]
40. Impact of Transcatheter Aortic Valve Implantation on Thrombin Generation and Platelet Function.
Mourikis P; Dannenberg L; Zako S; Helten C; M'Pembele R; Richter H; Hohlfeld T; Jung C; Zeus T; Kelm M; Veulemans V; Polzin A
Thromb Haemost; 2021 Oct; 121(10):1310-1316. PubMed ID: 33759144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
